We encountered a rare case of rapidly progressive mixed adenoneuroendocrine carcinoma that was negative for HER2 expression after T-mab treatment combined with chemotherapy. This evidence concerns the gene ERBB2 and digestive system mixed adenoneuroendocrine carcinoma.